COVID-19 has spread around the planet, sending billions of people into lockdown as health services struggle to cope. The statistics are startling global cases stand at 23,139,628 and with a total death toll of 801,795 and new daily cases rising (John Hopkins University data 23 Aug 2020), the outbreak has thrown an unprecedented challenge to the world and its citizens
KENILWORTH, N.J., & BRUSSELS--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and the European Organisation for Research and Treatment of Cancer (EORTC) today announced new and updated findings from the Phase 3 EORTC1325/KEYNOTE-054 trial evaluating KEYTRUDA, Mercks anti-PD-1 therapy, as adjuvant therapy in resected, high-risk stage III melanoma. Late-breaking, first-time study results showed that with 3.5 years of follow-up, adjuvant KEYTRUDA met the key secondary endpoint of distant metastasis-free survival (DMFS), reducing the risk of distant metastasis or death by 40% versus placebo (HR=0.60 [95% CI, 0.49-0.73]; p 1 mm lymph node metastasis), IIIB and IIIC melanoma, with 3.5-year RFS rates of 59.8% for KEYTRUDA versus 41.4% for placebo (HR = 0.59 [95% CI, 0.49-0.70]; p 1 mm lymph node metastasis], IIIB and IIIC). The co-primary endpoints are RFS for all patients and RFS in patients whose tumors expressed PD-L1.
Stemson Therapeutics announced that it has raised a $7.5 million seed round of funding led by Allergan Aesthetics (an AbbVie Company) and impact investor Fortunis Capital to advance the development of Stemsons therapeutic solution to cure hair loss. This funding round enables Stemson to advance its goal of restoring human hair growth with a novel approach using the patients own cells to generate new hair follicles
Key Developments in the Market: In March 2018, Kaneka Corporation announced that they have acquired a patent in the Japan for the creation of the method to mass-culture pluripotent stem cells including iPS cells and ES cells. This will help the company to use the technology to produce high quality pluripotent stem cells which can be used in the drug and cell therapy.
In November, California voters will be deciding on a dozen statewide ballot measures. One is about funding stem cell research through bonds, Proposition 14. Just one day before his high school graduation, Cal Poly football recruit Jake Javier dove into a friends swimming pool and hit his head on the bottom, leaving him paralyzed from the chest down
The report titled Synthetic Stem Cells Marketoffers a primary impression of the Synthetic Stem Cells industry covering different productScope, Characterizations, Classifications, Objectives, and Participantsin the industry chain structure. Synthetic Stem Cells Market (6 Forces Forecast 2020-2026) research report offers in-intensity insight of the Synthetic Stem Cells industry masking all vital parameters along with Marketing Channel, Direct Marketing, Indirect Marketing,Brand Strategy, Pricing Strategy,Market Positioning, Target Client, and Distributors/Traders List. Synthetic Stem Cells market report profiles major topmost manufactures operating (North Carolina State University, Zhengzhou University) in terms of analyses various attributes such asCompany Profile, Product Specifications, Revenue, Gross, Gross Margin, Cost, Capacity, CAGR, Production Valueand contact information.
Asymmetrex Receives $0.42 Million R&D Award from NIH-NHLBI BOSTON (PRWEB) September 22, 2020 On the heals of Asymmetrexs recently published peer-reviewed report describing its development of a method for quantifying therapeutic tissue stem cells, on Saturday September 19, the company received a Notice of Award of its first Phase I Small Business Innovation Research (SBIR) grant from the U.S. National Institutes of Health. Sponsored by the National Heart Lung and Blood Institute, the $0.42 million 1 year award recognizes the potential major impact of Asymmetrexs first-in-kind technology in the stem cell medicine and drug development industries
CT scan of patients lungs showing COVID-19 damage in red.
The progressive growth trail of Vaccine, Insulin and Stem Cell Market covering global, regional, country-level Analysis from 2015-2027 is studied in this report.
The global Stem Cell Cryopreservation Equipments Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Stem Cell Cryopreservation Equipments Market
Recent Comments